Some Canadian Web Sites Sell Counterfeit Drugs

By Katharine Davis | September 1, 2006 11:55 am

The Food and Drug Administration (FDA) is warning consumers not to buy prescription drugs from certain Canadian Web sites because some drugs sold on these Web sites were found to be counterfeit.

The Internet pharmacies in question are those that have their orders filled by a company called Mediplan Prescription Plus Pharmacy or Mediplan Global Health, which is based in Manitoba, Canada. They include the following sites:

FDA investigators intercepted shipments of drugs ordered from these Web sites and analyzed the drugs. The investigators found counterfeit versions of several drugs, including the cholesterol-lowering drugs atorvastatin (brand name Lipitor), rosuvastatin (Crestor), and ezetimibe (Zetia); the blood-pressure-lowering drugs valsartan (Diovan) and losartan plus hydrochlorothiazide (Hyzaar); the arthritis pain reliever celecoxib (Celebrex); and the osteoporosis drug risedronate (Actonel).

Counterfeit drugs are not manufactured according to FDA standards, so they may contain too little or too much of the active ingredient or may be contaminated with harmful ingredients. If you have purchased drugs from the Web sites listed above, the FDA strongly recommends that you do not use them.

Advertisement

Source URL: http://www.diabetesselfmanagement.com/blog/some-canadian-web-sites-sell-counterfeit-drugs/


Katharine Davis: Katharine Davis is a former Web Editor of DiabetesSelfManagement.com

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.